Results 241 to 250 of about 1,913,070 (304)

Chronic lymphocytic leukemia.

Experimental oncology, 2013
openaire   +2 more sources

Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases

European Journal of Haematology, EarlyView.
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion ...
Mathias Lazarevic Lindblad, Elin Pålsson, Vladimir Lazarevic, Leila Naddi, Ola Borgquist, Lars Nilsson, Maria Adrian, Björn P. Bark, Thomas Kander   +8 more
wiley   +1 more source

Zanubrutinib, a New Bullet Against Chronic Lymphocytic Leukemia Even When Localized in Central Nervous System. [PDF]

Case Rep Hematol
D'Amato M, Baratè C, Cervetti G, Caparello M, Ortenzi V, Naccarato AG, Benedetti E, Galimberti S.   +7 more
europepmc   +1 more source

The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia.

Blood
Al-Sawaf O, Locher BN, Christen F, Hablesreiter R, Rajamani A, Robrecht S, Zhang C, Fink AM, Tausch E, Schneider C, Ritgen M, Kreuzer KA, Kopp K, Mertz ME, Fustero-Torre C, Kleo K, Seymour J, Blombery P, Bullinger L, Chyla B, Jin HY, Jiang Y, Stilgenbauer S, Hallek M, Eichhorst B, Langerbeins P, Fischer K, Damm F.   +27 more
europepmc   +1 more source

Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemia. [PDF]

BMC Med
Castronuovo M, Capasso G, Beltrame A, Mouawad N, Gramegna V, Fantato P, Pagnin E, Angotzi F, Cellini A, Serafin A, Facco M, Visentin A, Trentin L, Frezzato F.   +13 more
europepmc   +1 more source

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia. [PDF]

Hemasphere
De Falco F, Del Papa B, Sorcini D, Valmarini L, Adamo FM, Atzeni A, Esposito A, Silva Barcelos EC, Dorillo E, Stella A, Arcaleni R, Gurrieri F, Pugliese M, Astolfi G, Martelli MP, Di Ianni M, Rosati E, Sportoletti P.   +17 more
europepmc   +1 more source

Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States. [PDF]

Future Oncol
Brown JR, Munir T, Lipsky AH, Challagulla S, Campbell D, Yang K, Fu Q, Aldairy W, Williams R, Tam CS.   +9 more
europepmc   +1 more source

Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia. [PDF]

Future Oncol
Hou JZ, Choksi R, Maglinte GA, Wang X, Rui PA, Suryavanshi M, Allendorf D, Patel T, Dadla A, Fontaine A, Jonglertham P, Aton L, Hagan M, Morere L, Scott J, Williams R, Ermann DA.   +16 more
europepmc   +1 more source

Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis. [PDF]

Cancers (Basel)
Wojnicka J, Kiełbus M, Mertowska P, Mertowski S, Grywalska E, Sosnowski P, Wielgosz A, Kozub-Pędrak A, Sosnowska-Pasiarska B, Klatka M, Klatka J, Błażewicz A.   +11 more
europepmc   +1 more source

Treatment of advanced cutaneous squamous cell carcinoma with cemiplimab in elderly multimorbid patients – a case series

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Patryk Porebski, Katharina Amschler, Michael P. Schön, Kai‐Martin Thoms   +3 more
wiley   +1 more source